Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Blackledge

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
International Journal of Bio-Medical Computing|September 1, 1981
A microprocessor-based system for clinical cancer studies: data management and analysisG Blackledge, R Swindell, D Crowther
Urology|August 15, 2001
Growth factors and their receptors: new targets for prostate cancer therapyJ Barton, G Blackledge, A Wakeling
Anti-Cancer Drugs|January 1, 1996
Bicalutamide: a new antiandrogen for use in combination with castration for patients with advanced prostate cancerG Blackledge, G Kolvenbag, A Nash
Lancet (London, England)|November 8, 1986
Ifosfamide/mesna nomogram and serum albuminG Constantine, C Meanwell, G Blackledge
British Medical Journal (Clinical Research Ed.)|March 19, 1988
Pancreatic cancerJ P Neoptolemos, G Blackledge, D Spooner
Journal of the Royal Society of Medicine|November 1, 1979
Role of computed tomography in staging and management of gastrointestinal lymphomaG Blackledge, J K Best, D Crowther
Clinics in Haematology|October 1, 1979
The role of computed tomography of the abdomen in the diagnosis and staging of patients with lymphomaD Crowther, G Blackledge, J K Best
Prostate Cancer and Prostatic Diseases|December 24, 2002
Anti-EGF receptor therapyG Blackledge, S Averbuch, A Kay, et al.
Cancer Treatment Reports|March 1, 1984
Phase II evaluation of bleomycin in patients with advanced epithelial ovarian cancerG Blackledge, F Lawton, H Buckley, et al.
Gynecologic and Obstetric Investigation|January 1, 1989
Urinary polyamine excretion patterns in patients with epithelial ovarian cancerF Lawton, M Griffin, J Slack, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
International Journal of Bio-Medical Computing|September 1, 1981
A microprocessor-based system for clinical cancer studies: data management and analysisG Blackledge, R Swindell, D Crowther
Urology|August 15, 2001
Growth factors and their receptors: new targets for prostate cancer therapyJ Barton, G Blackledge, A Wakeling
Anti-Cancer Drugs|January 1, 1996
Bicalutamide: a new antiandrogen for use in combination with castration for patients with advanced prostate cancerG Blackledge, G Kolvenbag, A Nash
Lancet (London, England)|November 8, 1986
Ifosfamide/mesna nomogram and serum albuminG Constantine, C Meanwell, G Blackledge
British Medical Journal (Clinical Research Ed.)|March 19, 1988
Pancreatic cancerJ P Neoptolemos, G Blackledge, D Spooner
Journal of the Royal Society of Medicine|November 1, 1979
Role of computed tomography in staging and management of gastrointestinal lymphomaG Blackledge, J K Best, D Crowther
Clinics in Haematology|October 1, 1979
The role of computed tomography of the abdomen in the diagnosis and staging of patients with lymphomaD Crowther, G Blackledge, J K Best
Prostate Cancer and Prostatic Diseases|December 24, 2002
Anti-EGF receptor therapyG Blackledge, S Averbuch, A Kay, et al.
Cancer Treatment Reports|March 1, 1984
Phase II evaluation of bleomycin in patients with advanced epithelial ovarian cancerG Blackledge, F Lawton, H Buckley, et al.
Gynecologic and Obstetric Investigation|January 1, 1989
Urinary polyamine excretion patterns in patients with epithelial ovarian cancerF Lawton, M Griffin, J Slack, et al.
Pageof 10